L
Leben Salud | Fundacion Medica de Rio Negro y Neuquen
Research site
(Unclaimed)
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
1 of 1 total trial
The primary objectives of this study are to observe the safety and tolerability of bemarituzumab and to evaluate preliminary antitumor activity.
Enrolling
Solid Tumors
Drug: Bemarituzumab
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems